Arbutus Biopharma (ABUS)'s 30-day implied volatility (IV30) was 46.1% at the close on October 21, 2026, up from 39.2% the day before, against a 52-week range of 29.7% to 167.9%. Its 20-day historical volatility was 43.0%.
Data as of October 21, 2026.